Canada is the only developed country in the world without a federal healthcare policy for persons with rare disorders. Read more.
With 2012 underway this story looks at some of the exciting opportunities in the venture capital world. Read more.
As a celebration of Canadian innovation, BIOTECanada's 2012 Gold Leaf Awards program provides the opportunity to recognize both companies and individuals who have made significant achievements to our industry over the last year. Find out more.
Join Deloitte Partners Albert de Luca in Montreal and Anil Chawla in Toronto as they present Tax Incentives for life sciences: A comparion between Quebec, Ontario and Massachusetts. Find out more about Deloitte services for members, click here. Read more.
Attending BIO CEO & Investor Conference? February 13 - 14 in NYC. Meet international leaders from biotech, pharma and finance, along with the most promising start-ups and early stage projects. Members save $700 on registration. Learn more here.
BIOTECanada is the national non-profit association dedicated to building the bio-economy in Canada. From cleaner energy to sustainable agriculture; from greener manufacturing to life-saving health therapies, Canadian biotech firms are discovering ways to revolutionize the economy and improve our lives, everyday.
Watch an exlusive interview with Peter Brenders, President and CEO BIOTECanada to find out about recent deals and news from the Canadian biotech industry.
January 20, 2012
Jets test fuel from new oilseed by D'Arce McMillan, Stockhouse
January 3, 2012
Enobia Lands $1 Billion Deal by Kevin Grogan, PharmaTimes
December 20,
2011
Canadian-made
HIV vaccine approved for human testing CTV News
December 14,
2011
Harnessing
nanotechnology in the fight against cancer by Bertrand Marotte, Globe and
Mail